We are live on ! Find out more

25 hedge funds and large institutions have $2.28M invested in Imunon in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

18% more call options, than puts

Call options by funds: $67K | Put options by funds: $57K

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

0.04% less ownership

Funds ownership: 0.08%0.04% (-0.04%)

26% less funds holding

Funds holding: 3425 (-9)

39% less capital invested

Capital invested by funds: $3.76M → $2.28M (-$1.48M)

82% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 11

Holders
25
Holders Change
-9
Holders Change %
-26.47%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
7
Reduced
7
Closed
11
Calls
$67K
Puts
$57K
Net Calls
+$10K
Net Calls Change
-$65K

IMNN Hedge Fund Activity: Q4 2020 in Review

25 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2020, worth a combined $2.28M — down 39% from $3.76M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of IMNN and 2 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 7 added.

The largest buyer was Squarepoint, opening a new position worth an estimated $81.4K. The largest seller was Morgan Stanley, cutting an estimated $407K.

  • 25 institutional investors held Imunon (IMNN) as of Q4 2020, down from 34 in Q3 2020.
  • Funds reported $2.28M of Imunon stock for Q4 2020, down 39% quarter-over-quarter.
  • 2 funds opened new Imunon positions in Q4 2020 and 11 closed out, a net change of -9 holders.
  • The largest Imunon buyer in Q4 2020 was Squarepoint, an estimated $81.4K added.
  • The largest Imunon seller in Q4 2020 was Morgan Stanley, an estimated $407K sold.

Based on aggregated 13F filings for Q4 2020.